COVID-19 Resource Center

As the numbers of physicians specializing in infectious diseases continues to fall short of need, nearly two-thirds of Americans live in areas with little or no access to an infectious diseases specialist, according to a study published online today in the Annals of Internal Medicine.

The incomprehensible death of George Floyd has left our country grieving and demands attention to the environment of disparities, inequities and structural racism in which it occurred. As infectious diseases and HIV health care providers, we stand against discrimination in any form.

Summarized here are the recommendations with comments related to the clinical practice guideline for the treatment and management of COVID-19.

Meeting requested to address questions, inform planning for use of remdesivir, the only FDA-authorized drug for COVID-19 treatment.

H.R.6800, the Health Heroes Act, includes policies and investments that would bolster the federal response to COVID-19, increase testing capacity and availability of medical supplies and address the disparate impact of COVID-19 on vulnerable populations.